Akèy › Maladi poumon › South Carolina
Etid klinik pou Maladi poumon nan South Carolina
11 etid pou Maladi poumon ap chèche patisipan nan sit nan South Carolina.
Vil nan South Carolina
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Medical University of South Carolina, Charleston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 25 a 35 · Tout sèks · Mizajou Sep 23, 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research of Rock Hill, Rock Hill
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Medical University of South Carolina, Charleston
- Prisma Health Cancer Institute, Greenville
- Lexington Medical Center, West Columbia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Research of Rock Hill, Rock Hill
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Charleston
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Bogan Sleep Consultants, LLC, Columbia
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Medical University of South Carolina, Charleston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2025 · NCT04555161Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.